Elliott Jeffrey Thomas's Form 4 filing
Exact Sciences Corp (EXAS) · filed Aug 2, 2021
- Accession no.
- 0001209191-21-049081
- Filed
- Aug 2, 2021
- Trade date
- Apr 30-Jul 29, 2021
- Filing delay
- 94 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market sales total $4.27M. It was filed 94 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001209191-21-049201 (Aug 3, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elliott Jeffrey ThomasCIK 0001689757 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2021 | Common Stock | AGrant or awardAcquired | +206 | $103.22 | +$21,263.32 | 38,567 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −1,200 | $107.54F2 | −$129,048 | 37,367 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −1,066 | $108.54F3 | −$115,703.64 | 36,301 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −2,602 | $109.58F4 | −$285,127.16 | 33,699 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −7,818 | $110.64F5 | −$864,983.52 | 25,881 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −13,853 | $111.58F6 | −$1,545,717.74 | 12,028 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −8,675 | $112.39F7 | −$974,983.25 | 3,353 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −1,899 | $113.35F8 | −$215,251.65 | 1,454 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −1,248 | $114.41F9 | −$142,783.68 | 206 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.16 to $107.92, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.23 to $108.73, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.95, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $110.99, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $111.998, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.99, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.02 to $113.895, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.165 to $114.63, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
Referenced by the price of 1 transaction in Table I.